Exercício aeróbico baseado no primeiro limiar ventilatório em pacientes com excesso de peso e doença renal crônica: impacto sobre a capacidade cardiorrespiratória e funcional by Aoike, Danilo Takashi et al.
Artigo originAl | originAl Article
139
Autores
Danilo Takashi Aoike1
Flavia Baria1
Mariana Leister Rocha1
Maria Ayako 
Kamimura1
Marco Túlio de Mello1
Sergio Tufik1
Adriano Ammirati2
Lilian Cuppari1,2
1Universidade Federal de 
São Paulo – UNIFESP. 
2Fundação Oswaldo 
Ramos – UNIFESP.
Data de submissão: 19/10/2011 
Data de aprovação: 25/02/2012
Correspondência para:  
Lilian Cuppari 
Rua Pedro de Toledo, 282 
Vila Clementino 
São Paulo – SP – Brasil 
CEP 04039-000 
E-mail: lcuppari@uol.com.br
Suporte financeiro:  
FAPESP
O referido estudo foi 
realizado na UNIFESP/EPM 
e no CEPE/AFIP. 
Os autores declaram a 
inexistencia de conflitos  
de interesse.
Resumo
Introdução: O excesso de peso e a doen-
ça renal crônica (DRC) estão associados 
à baixa capacidade cardiorrespiratória 
(CR) e funcional (CF). Já foi observado 
que o treinamento aeróbico (TA) me-
lhora a CR e CF. Métodos indiretos e 
subjetivos são comumente empregados 
para a prescrição da intensidade do TA. 
O limiar ventilatório (LV) é um método 
direto e objetivo que permite prescrever 
a intensidade do TA de acordo com a 
capacidade física do paciente. Objetivos: 
Avaliar o impacto do TA com base na in-
tensidade do LV sobre a CR e CF de pa-
cientes com excesso de peso e portadores 
de DRC na fase não dialítica. Métodos: 
Dez pacientes (oito homens; 49 ± 10,1 
anos, IMC 30,4 ± 3,5 kg/m2, depuração 
de creatinina 39,4 ± 9,8 mL/min/1,73m²) 
foram submetidos à TA 3 vezes por se-
mana durante 12 semanas. CR (ergoes-
pirometria), CF e parâmetros clínicos 
foram avaliados. Resultados: O TA pro-
moveu aumento de 20% no consumo 
pico de O2 (VO2pico), 16% na velocidade 
alcançada no VO2pico e melhora em 9,2% 
na caminhada de seis minutos, 20,3% na 
marcha estacionária, 35,7% no sentar e 
levantar, 16,3% na resistência muscular 
de membro superior e 15,3% no tempo 
de ir e voltar. A pressão arterial dimi-
nuiu sem modificação nos anti-hiperten-
sivos, no peso ou no consumo de sódio. 
Conclusão: Os resultados indicam que o 
TA baseado na intensidade do LV melho-
ra a CR, CF e pressão arterial de pacien-
tes portadores de DRC com excesso de 
peso. Isso sugere que o TA baseado na 
intensidade LV é eficaz e pode ser em-
pregado com segurança nesses pacientes. 
AbstRAct
Introduction: Chronic kidney disease 
(CKD) and obesity are both associated 
with reduced physical capacity. The po-
tential benefit of aerobic training on phy-
sical capacity has been recognized. The 
exercise intensity can be established using 
different methods mostly subjective or 
indirect. Ventilatory threshold (VT) is a 
direct and objective method that allows 
prescribing exercise intensity according to 
individual capacity. Objectives: To evalu-
ate the impact of aerobic training at VT 
intensity on cardiopulmonary and func-
tional capacities in CKD patients with ex-
cess of body weight. Methods: Ten CKD 
patients (eight men, 49.7 ± 10.1 years; 
BMI 30.4 ± 3.5 kg/m2, creatinine clearan-
ce 39.4 ± 9.8 mL/min/1.73 m2) underwent 
training on a treadmill three times per 
week during 12 weeks. Cardiopulmonary 
capacity (ergoespirometry), functional 
capacity and clinical parameters were 
evaluated. Results: At the end of 12 we-
eks, VO2peak increased by 20%, and the 
speed at VO2peak increased by 16%. The 
training resulted in improvement in func-
tional capacity tests, such as six-minute 
walk test (9.2%), two-minute step test 
(20.3%), arm curl test (16.3%), sit and 
stand test (35.7%), and time up and go 
test (15.3%). In addition, a decrease in 
systolic and diastolic blood pressures was 
observed despite no change in body wei-
ght, sodium intake and antihypertensive 
medication. Conclusion: Aerobic exerci-
se performed at VT intensity improved 
cardipulmonary and functional capacities 
of overweight CKD patients. Additional 
benefit on blood pressure was observed. 
These results suggest that VT can be 
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IntRoductIon 
Patients with chronic kidney disease (CKD) have low 
cardiopulmonary and functional capacities that are 
expressed by reduced oxygen uptake (VO2), decreased 
daily activity and low exercise tolerance.1,2 Low car-
diopulmonary fitness and functional capacity of these 
patients become evident when one notes that the peak 
of VO2 (VO2peak) is on average 50% lower than that 
of healthy sedentary individuals of the same age.2,3 In 
addition, they have a reduction of about 40 to 50% in 
muscle strength2,3 as a consequence of muscle atrophy, 
reduced capillarization, increased peripheral vascular 
resistance4 and decreased arterial compliance.5
Physical inactivity, a condition commonly seen in 
over weight and obese individuals, is in general as-
sociated with low cardiopulmonary and functional 
capacities as well. Recent data demonstrated that the 
prevalence of excess of body weight has remarkably 
increased among patients with CKD.6 The association 
of both diseases may aggravate the physical capacity 
and consequently the quality of life of these patients. 
Indeed, low cardiopulmonary fitness and functional 
capacity are associated with greater risk of morta-
lity, hospitalization and morbidity in patients with 
CKD.7,8 On the other hand, exercise improves cardio-
pulmonary and various aspects of functional capacity 
in CKD patients.2,9
Exercise intensity can be prescribed based upon 
ratings of perceived physical exertion, metabolic 
equivalent, estimated or measured maximal heart rate 
and measured VO2peak. The methods based on the re-
lationship between different percentages of maximal 
heart rate or VO2peak have been the most commonly 
used strategies for exercise prescription in general po-
pulation.10 The ideal physical exercise protocol has 
not been established for patients with CKD.11 The 
effective exercise prescription should not only ensure 
a sufficient training stimulus to yield the relevant he-
alth benefits, but should also do it without over-exer-
tion and unnecessary discomfort, thereby promoting 
safety and exercise adherence.10-12 
In line with these assumptions, the use of the ven-
tilatory threshold (VT) as a target for determining 
the exercise intensity seems to be a more appropriate 
method to be used for patients with CKD. The VT is 
defined as the maximum exercise intensity fully sup-
ported by aerobic metabolism, representing in general 
a mild to moderate exercise intensity.13,14 Additionally, 
since the VT is a direct and objective measure of car-
diopulmonary capacity, the intensity of the exercise is 
determined individually according to physical capaci-
ty and it is independent of the patient’s motivation.15 
Studies using the VT for prescribing the exercise 
intensity for patients with severe chronic diseases are 
scarce, but in most of them the benefits achieved were 
similar to those of higher intensity.15,16 To our know-
ledge, only two studies have used the VT for prescri-
bing the training intensity in patients with CKD and 
both were performed with patients on dialysis.17,18 
The purpose of the present study was to investigate in 
overweight patients with CKD the impact of an aero-
bic training prescribed according to VT on cardiopul-
monary and functional capacities.
methods
PAtients 
Ten patients with CKD in the non-dialysis stage (sta-
ges 3 and 4) were recruted from the outpatient cli-
nic from the Oswaldo Ramos Foundation according 
to the following criteria, body mass index (BMI) 
> 25 kg/m2, age between 18 and 65 years, systolic 
blood pressure (BP) < 180 mmHg and diastolic BP 
< 100 mmHg, serum hemoglobin > 11 g/dL, glycated 
hemoglobin (HbA1c) < 8%, and absence of chronic 
obstructive pulmonary disease, congestive heart failu-
re or active coronary disease. Patients using beta blo-
ckers or erythropoietin and with positive ergometric 
test were not included.
Patients were informed of the purpose of the study 
protocol and signed an informed consent form. The 
study was approved by the Ethics Committee of 
the Federal University of São Paulo.
study Protocol
This was a prospective, non-controlled interventio-
nal study. All patients were seen by a nephrologist 
at baseline, 6 weeks and 12 weeks. Clinical, physi-
cal, laboratorial and quality of life assessments were 
Palavras-chave: Doença Renal Crônica. Obesidade. 
Exercício. Terapia por Exercício.
effectively applied for prescribing exercise intensity in 
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performed at baseline and after 12 weeks. The trai-
ning sessions using a treadmill were performed in the 
Psychobiology and Exercise Study Center. All ses-
sions were performed under supervision in regards to 
intensity and duration of the exercise.
trAining Protocol
The training program was conducted in accordance 
with the recommendations of the American College 
of Sports Medicine.12 All training sessions were prece-
ded by stretching of large muscle groups and heating 
(five minutes) and, at the end, by cool down and stre-
tching (five minutes). The program lasted 12 weeks 
with three sessions per week on alternate days. The 
aerobic training was continuous, with an increment 
of ten minutes in duration every four weeks. The in-
tensity was prescribed according to VT, characteri-
zed by the highest intensity of physical exertion fully 
maintained by aerobic energy pathways. The VT is 
considered a marker of exercise consistent with mild 
to moderate intensity and is usually found between 
40 to 60% maximum VO2 (VO2máx).
19-21 The intensity 
control was done by means of the heart rate value 
obtained at VT.
ergometric And cArdioPulmonAry exercise test
The tests were performed on a treadmill. Ergometric 
test was performed by a physician for cardiac eva-
luation and as an adaptation to minimize the lear-
ning effect in cardiopulmonary exercise testing. The 
Bruce’s modified protocol was applied for the ergo-
metric test.22 The cardiopulmonary exercise test was 
used to determine the VO2peak since patients with seve-
re chronic diseases usually do not meet the criteria for 
determining the VO2máx.
9 The test began with a fixed 
inclination of 1%. The initial velocity was 3 km/h 
during the first three minutes with increments of 0.5 
km/h every minute until the patient reaches physical 
exhaustion.
The ventilatory variables were measured using 
a gas analyzer (Quark PFT Cosmed 4, Rome, Italy) 
and were collected by the method of breath by bre-
ath. Before each test, the analyzer was calibrated wi-
th reference gases. The highest VO2 obtained during 
the last stage reached was considered the VO2peak. The 
VT was determined as the stage preceding the first 
occurrence of the exponential increase in ventilation, 
increase in the ventilatory equivalent for oxygen (VE/
VO2) and increase in expired fraction of oxygen. The 
respiratory compensation point (RCP) was determi-
ned as the stage preceding the second occurrence of 
the exponential increase in ventilation, increase in the 
ventilatory equivalent for carbon dioxide (VE/VCO2) 
and decrease in end-tidal carbon dioxide. Data were 
analyzed by the average of 20 seconds.
FunctionAl cAPAcity tests
Functional capacity was assessed using a variety of 
objective measures. These included six-minute walk 
test (maximal distance walked along an internal cor-
ridor during six minutes), two-minute step test (ma-
ximal number of steps achieved in stationary walking 
during two minutes, used to quantifying the aerobic 
power), sit-to-stand test (maximal sit to stand cycles 
achieved in 30 seconds, used to quantifying the mus-
cular endurance of the legs), arm curl test (maxi-
mal number of arm curl cycles in 30 seconds, used 
to quantifying the muscular endurance of the arms), 
sit and reach test (maximal distance achieved in the 
Wells bench, used to quantifying the general flexibili-
ty), back scratch test (maximum amplitude of the ar-
ms used to quantifying the arms flexibility) and time 
up and go test (shorter time to rise from a chair, walk 
three meters and sit back, used to quantifying the 
functional mobility). In order to minimize the effect 
of learning, the patients were previously submitted to 
a pre-test. All tests were applied in accordance with 
the methods described by Rikli.23
QuAlity oF liFe Assessment
The Short-Form Health Survey (SF-36) questionnaire 
was applied to assess the quality of life.24 The scores 
for each domain range from 0 to 100%. The higher 
scores define a better quality of life. The questionnai-
re was applied individually in a clear and quiet room 
with the patient rested.
AnthroPometric, lAborAtory And clinicAl 
meAsurements
Body weight and height were measured to determine 
body mass index (BMI). Blood was collected with the 
patient fasted for eight hours. Serum creatinine, urea, 
glucose, sodium, potassium, calcium, phosphorus, 
glycated hemoglobin, albumin (bromcresol green), 
hemoglobin, pH, bicarbonate (automated potentio-
meter) were determined. Twenty four-hour urine was 
collected for determination of creatinine clearance, 
urinary sodium and urea. Protein equivalent of nitro-
gen appearance (PNA) was determined using 24-hour 
urinary urea nitrogen, according to Sargent & Gotch’s 
equation.25 Blood pressure and resting heart rate were 
measured before the cardiopulmonary exercise test.
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stAtisticAl AnAlysis
Data are presented as mean and standard deviation 
or median and interquartile. Skewed variables were 
log or squared root transformed. Paired Student’s t-test 
or Wilcoxon test were used to compare variables be-
tween baseline and 12 weeks. P-values < 0.05 were 
considered statistically significant. The SPSS® softwa-
re version 15.0 for Windows (SPSS Inc., Chicago, IL, 
USA) was used for analysis.
Results
The study included ten CKD patients (eight men; ei-
ght stage 3 and two stage 4; 49.7 ± 10.1 years, BMI 
30.4 ± 3.5 kg/m2). The etiologies of kidney disease were 
hypertensive nephropathy (n = 4), tubule interstitial ne-
phropathy (n = 2), chronic glomerulo nephritis (n = 2) 
and polycystic kidneys (n = 2). Only one patient had 
diabetes mellitus. At baseline, all patients were in use 
of antihypertensive medication, and sodium bicarbo-
nate had been prescribed for nine patients. During the 
follow-up, one patient required a reduction in the an-
giotensin converting enzyme inhibitor dosage, and for 
another patient the dose of sodium bicarbonate was 
reduced by half. No other changes in medication were 
needed. All enrolled patients completed the study pe-
riod. Eight patients attended more than 80% of the ma-
ximum of 36 sessions during the 12 weeks. The remai-
ning two patients attended at least 75% of the sessions.
The cardiopulmonary parameters during the 
follow-up are depicted in Table 1. As can be seen, 
both absolute and relative VO2peak increased after 
12 weeks of training. The increase of these parameters 
was on average 20.7% (95%CI 12 – 29%) and 20% 
(95%CI 11 – 29%), respectively. Consistent with the 
increase in VO2peak, the maximal ventilation and the 
speed in VO2peak were significantly increased. Variables 
at VT, such as VO2, %VO2peak and heart rate remained 
unchanged. However, the speed at VT increased sig-
nificantly. Moreover, at RCP, an increase of VO2 and 
speed with no change in %VO2peak and heart rate were 
observed. Figure 1 shows the speed achieved at VT, 
RCP and at VO2peak at baseline and after 12 weeks. It is 
noteworthy that the speed achieved at VT after 12 we-
eks (5.9 ± 0.7 km/h) was similar to the speed achieved 
at RCP at baseline (6.0 ± 0.7 km/h, p = 0.86).
The results of functional capacity tests are demons-
trated in Table 2. Except for sit and reach test, stand 
and reach test, and back scratch test, that remained 
unchanged, all other tests were improved. The six-mi-
nute walk test and two-minute step test increased by 
an average of 9.2% (95%CI 5.1 – 13.2%) and 20.3% 
(95%CI 11.8 – 28.8%) respectively. The arm curl 
test and sit and stand test increased by an average of 
16.3% (95%CI 8.9 – 23.7%) and of 35.7% (95%CI 
17 – 54.4%) respectively. The time up and go test re-
duced by 15.3% (95%CI 7.8 – 22.9%) after 12 weeks.
As seen in Table 3, improvement in the functional 
domain and a tendency to increase the general heal-
th perception were found in the SF-36. Table 4 sum-
marizes the clinical and laboratory characteristics of 
patients at baseline and after 12 weeks of training. 
Body weight, as well as most laboratory parameters, 
remained unchanged. Serum urea and PNA decrea-
sed significantly, and there was a trend of increasing 
serum bicarbonate. Both systolic and diastolic blood 
pressure decreased significantly. The resting heart ra-
te tended to decrease. No cardiovascular, metabolic, 
osteoarticular or skeletal-muscle adverse events were 
observed during the follow-up.
dIscussIon
In the present study, we found that the use of VT as a 
target for establishing the exercise intensity was well-to-
lerated and resulted in improvement of cardiopulmonary 
and functional capacity of the non-dialyzed CKD patients 
with excess of body weight.
Few exercise studies have been performed with 
patients in the non-dialysis stage of CKD and, to the 
best of our knowledge, none of them employed VT 
for establishing the training intensity. All studies with 
this group of CKD patients used indirect methods, su-
ch as arbitrary percentage of VO2peak,
26 the percentage 
of maximum effort in conjunction with the Borg sca-
le27 or the percentage of heart rate reserve.28 Although 
valid, the mentioned methods do not guarantee that 
the intensity of exercise coincides with that based on 
VT, which ensures a fully aerobic intensity and gua-
rantee that the exercise is performed according to the 
capacity of each patient. Indeed, depending on the 
percentage of VO2peak chosen, the intensity of the exer-
cise can be inappropriately high. In the present study, 
the %VO2peak found at VT was on average 64.5%, va-
rying from 42.9 to 88.8%. Since the %VO2peak at VT 
has a large inter-subject variability, the precision of 
indirect methods in relation to VT can be compro-
mised, implicating for very low intensity for some or 
inappropriate high for others.
It is well known that repeated sessions at high 
intensity may increase the risk of over-reaching 
or over-training. Since overweight/obese CKD pa-
tients are potentially at high risk of cardiovascu-
lar disease29 and osteoarticular and skeletal muscle 
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injuries,30 training at high intensity may be harmful. 
Therefore, the use of VT for prescribing the exer-
cise intensity may be safer and more appropriate 
for these patients. Additionally, due to the low in-
tensity, this method may offer a better compliance 
of the patients. In accordance, no withdraw was 
observed in the present study and there was a high 
degree of compliance to the training sessions. To 
date, there are only two reports with patients on 
dialysis that used the VT to prescribe the training. 
In the study by Koufaki et al., 33 patients under-
going hemodialysis (HD) or peritoneal dialysis the 
VO2peak increased by 15% after 12 weeks of training 
in a cycle ergometer 3 times per week.17 In another 
study, also using a cycle ergometer during 24 we-
eks, the increase in VO2peak was on average 20% in 
a group of 24 patients on HD.18
Despite using a low intensity training, the be-
neficial effects, in terms of cardiopulmonary, were 
evident in our study. Notably, the benefits were si-
milar or even better than that found in patients with 
CKD using higher intensity training. In the majo-
rity of studies with patients on dialysis whose the 
overload of exercise was greater, either in intensi-
ty (85% of VO2peak)
31-34 or in the volume of training 
(greater number of sessions or longer duration of 
session),35-38 the VO2peak increased on average 19%, 
which was very similar to that found in the current 
study (20.7%).
The raise in the VO2peak was accompanied by an in-
crease in the speed achieved at VT, as well as at RCP, 
indicating a higher metabolic efficiency for the same 
workload. Most important is the finding that the spe-
ed achieved at VT after the period of training was 
very similar to that achieved at RCP before training 
tAble 1 cArdioPulmonAry PArAmeters beFore And AFter 12 weeks oF trAining (n = 10)
Variables Baseline 12 weeks p-value
VO2peak absolute (mL/min) 1878.8 ± 426.5 2254.4 ± 539.8 0.002
VO2peak relative (mL/kg/min) 23.1 ± 5.3 27.6 ± 6.7 0.003
Maximal heart rate (bpm) 159.3 ± 13.3 160.0 ± 13.9 0.87
Maximal ventilation (L/min) 85.3 ± 23.7 98.2 ± 16.8 0.02
Speed in VO2peak(km/h) 7.5 (7.0–8.0) 8.7 (7.5–9.5) 0.007
VO2in VT (mL/kg/min) 14.4 ± 3.2 16.2 ± 3.9 0.12
%VO2peak in VT 64.5 ± 16.0 59.3 ± 6.8 0.47
Heart rate in VT (bpm) 115.1 ± 12.0 111.6 ± 9.6 0.43
Speed in VT (km/h) 4.7 ± 0.7 5.9 ± 0.7 0.001
VO2 in RCP (mL/kg/min) 17.4 ± 3.6 21.5 ± 4.9 0.009
%VO2peak in RCP 77.1 ± 13.2 78.6 ± 8.5 0.76
Heart rate in RCP (bpm) 130.4 ± 16.4 137.6 ± 12.2 0.27
Speed in RCP (km/h) 6.0 ± 0.7 7.2 ± 0.7 0.001
Data are presented as mean ± standard deviation or median and interquartile. VO2: oxigenuptake; VT: ventilatory threshold; 
RCP: respiratory compensation point.
 
 
VO 2peakRCPVT
*
*
*
4
5
6
7
8
9
S
pe
ed
 (k
m
/h
)
Baseline
12 Weeks
Figure 1. Speed at ventilatory threshold (VT), 
respiratory compensation point (RCP) and peak of the 
oxygen uptake (VO2PeAk). 
Data expressed in mean and 95%CI. *p < 0.01 – baseline versus 
12 weeks.
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(Figure 1). This means that the baseline workload, 
which was only possible to be achieved with a lar-
ge contribution of anaerobic metabolism (RCP), was 
reached almost exclusive by the aerobic metabolism 
(VT) after 12 weeks of training.
The benefits observed in the cardiopulmonary tests 
were also seen in the functional capacity tests. Indeed, 
after 12 weeks, the patients increased on average 
9.2% in the distance walked in the six-minute walk 
test. It is of note that the distance value achieved after 
the period of training was similar to that observed 
in sedentary healthy individuals.39,40 Improvement of 
functional capacity tests, particularly in the six-minute 
walk test, has also been observed in patients on dilay-
sis, independently of the type of exercise employed.41,42 
An important result of our study was found in the 
two-minute step test as well. The increase in the num-
ber of steps was on average 20.3%. There was also 
improvement of anaerobic characteristic tests, such as 
sit and stand test (35.7%), arm curl test (16.3%) and 
time up and go test (15.3%). Although the reason for 
this finding is not clear, since the training was aero-
bic, it could be attributed to psychological aspects, as 
motivation, better self-esteem and sense of well-being. 
A more efficient neuromuscular interaction could also 
be speculated.43
The improvement in the cardiopulmonary and 
functional capacities of patients was also perceived 
by a trend towards an increase in general health per-
ception score and a significant increase in the functio-
nal domain according to SF-36 questionnaire. Apart 
from the type of training, similar results have been 
found in several studies with patients undergoing 
hemodialysis.24,44,45
Of clinical importance, the 12-week training re-
sulted in a significant reduction of both systolic and 
Domains Baseline 12 weeks p-value
Physical functioning 87.5 (78.7 – 91.2) 95.0 (90.0 – 95.0) 0.01
Role physical 92.5 ± 23.7 100.0 ± 0 0.32
Bodily pain 84.0 (67.0 – 100.0) 100.0 (67.5 – 100.0) 0.92
General health perception 62.0 ± 14.3 68.8 ± 11.6 0.06
Vitality 77.5 (63.7 – 86.2) 85.0 (65.0 – 100.0) 0.23
Social functioning 100.0 (75.0 – 100.0) 100.0 (84.38 – 100.0) 0.28
Role emotional 90.0 ± 31.6 90.0 ± 22.5 0.97
Mental health 82.8 ± 16.8 84.0 ± 12.8 0.52
Total 87.5 (75.5 – 91.5) 91.2 (79.9 – 92.4) 0.44
tAble 3 score results oF sF-36 QuestionnAire beFore And AFter12 weeks oF trAining (n = 10)
Data are presented as mean ± standard deviation or median and interquartile.
tAble 2 FunctionAl cAPAcity PArAmeter As beFore And AFter 12 weeks oF trAining (n = 10)
Variables Baseline 12 weeks p-value
Six minutes walk test (m) 578.9 ± 49.9 631.8 ± 62.7 0.001
Two minutes step test (steps) 190.5 ± 32.8 228.2 ± 38.2 < 0.001
Time up and go test (sec) 6.3 ± 0.7 5.3 ± 0.8 0.002
Sit and reach test (cm) 18.9 ± 6.5 21.0 ± 7.1 0.06
Arm curl test - right arm (repetitions) 18.7 ± 3.7 22.5 ± 4.2 0.001
Arm curl test - left arm (repetitions) 19.0 ± 3.8 22.0 ± 4.2 < 0.001
Sit and stand test (repetitions) 17.9 ± 3.9 24.1 ± 5.6 0.001
Back scratch test – right arm (cm) 4.2 ± 6.9 5.9 ± 5.8 0.29
Back scratch test – left arm (cm) 7.8 ± 8.1 3.9 ± 7.9 0.23
Stand and reach test (cm) 90.9 ± 10.4 95.1 ± 5.5 0.11
Data are presented as mean ± standard deviation.
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diastolic blood pressures of the patients. The decrease 
in blood pressure due to mild/moderate aerobic exer-
cise has been well established both in normotensive 
and hypertensive individuals,46,47 as well as in CKD 
patients.28,48Aerobic training lowers blood pressure by 
reducing peripheral vascular resistance due to the im-
provement of endothelium-mediated vasodilatation, 
attenuation of increased sympathetic nervous system 
activity and vascular remodeling.46 Most important, 
the blood pressure reduction occurred in face of no 
modifications in the antihypertensive medication, so-
dium intake (estimated by the 24-h urinary sodium 
excretion) and body weight. It is of note that no spe-
cific dietary intervention aiming at body weight re-
duction was employed in the current study. Thus, it is 
possible to conclude that the benefits achieved herein 
may be attributed primarily to the exercise.
The reason for the tendency to increase serum bi-
carbonate after the 12 weeks of training is not cle-
ar. We could speculate that the patients were more 
compliant to the medication (sodim bicarbonate) sin-
ce in each monthly visit the adequate use of medica-
tion was reinforced. It is also possible that the decre-
ase in protein intake estimated by PNA could have 
contributed to the decrease of the acid load.
Although the present investigation has limitations, 
such as the small sample size and lack of a control 
group, some strengths deserve to be mentioned. First, 
we used an objective and reliable method for measu-
ring cardiopulmonary capacity. Second, the benefits 
on physical capacity and clinical aspects were clear-
ly evidenced by a set of markers of cardiopulmonary 
and functioning capacities.
Aerobic exercise performed at VT intensity im-
proved cardipulmonary and functional capacities 
of overweight CKD patients with no adverse effect. 
Additional benefit on blood pressure was observed. 
These results suggest that VT can be effectively ap-
plied for prescribing exercise intensity in this particu-
lar group of patients.
Variables Baseline 12 weeks p-value
Body weight (kg) 83.1 ± 12.7 83.5 ± 14.3 0.77
Serum creatinine (mg/dL) 3.1 ± 0.8 2.9 ± 0.7 0.32
Creatinine clearance (mL/min/1.73m²) 39.4 ± 9.8 40.1 ± 15.0 0.39
Urea (mg/dL) 108.9 ± 43.6 90.0 ± 39.7 0.008
Glucose (mg/dL) 94.0 ± 17.8 90.4 ± 14.6 0.24
Glycate hemoglobin (%) 5.83 ± 0.8 5.79 ± 0.4 0.89
pH 7.28 ± 0.5 7.28 ± 0.3 0.93
Bicarbonate (mmol/L) 18.3 (16.5 – 22.3) 22.7 (17.7 – 25.4) 0.06
Hemoglobin (g/dL) 13.9 (11.4 – 15.0) 14.2 (13.0 – 15.1) 0.88
Albumin (g/dL) 4.4 (4.2 – 4.5) 4.2 (4.1 – 4.3) 0.21
Calcium (mmol/L) 1.3 ± 0.05 1.3 ± 0.07 0.54
Phosphorus (mg/dL) 3.5 ± 0.7 3.6 ± 0.9 0.31
Serum sodium (mEq/L) 139.7 ± 1.3 142.4 ± 9.3 0.36
Potassium (mEq/L) 4.4 ± 0.4 4.5 ± 0.6 0.66
Urinay sodium (mEq/24hs) 232.3 ± 64.5 258.9 ± 112.5 0.31
PNA (g/dia) 82.0 ± 18.8 73.1 ± 19.6 0.035
CRP (mg/dL) 0,24 (0,11 – 1,1) 0,22 (0,13 – 0,4) 0,953
Systolic blood pressure (mmHg) 126.0 ± 8.4 112.5 ± 8.6 0.002
Diastolic blood pressure (mmHg) 80.0 ± 4.7 73.0 ± 6.7 0.02
Mean blood pressure (mmHg) 96.7 (93.3 – 97.5) 85.0 (82.9 – 90.8) 0.008
Resting heart rate (bpm) 77.0 ± 10.9 70.3 ± 8.7 0.06
tAble 4 clinicAl And lAborAtoriAl PArAmeters beFore And AFter 12 weeks oF trAining (n = 10)
Data are presented as mean ± standard deviation or median and interquartile. PNA: protein equivalent of total nitrogen appearance; 
CRP: c-reactive protein.
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